Jan H. Spaas was born in Belgium in 1986. He is a passionate horseback rider, which translated in winning a 2-fold bronze medal at European Championships and 3-fold bronze medal at Belgian Championships show jumping. Driven by a passion for veterinary medicine, he graduated as a veterinarian in 2010, obtained his PhD in stem cell research and was appointed visiting professor in 2020, all at the Faculty of Veterinary Medicine of Ghent University.

In 2012 he co-founded Global Stem cell Technology (GST) to develop regenerative therapies for horses, dogs and cats. He became Laboratory Director, Head R&D, Platform Leader and finally General Manager which is his current role as part of Boehringer-Ingelheim since 2020. Jan Spaas raised over 9.4 million euro of research funding and is promotor of several PhD students. He is inventor of 13 patent families and principal investigator of over 30 peer-reviewed international scientific publications. He is Associate Editor for Frontiers in Veterinary Science; a board member of the scientific society for equine health (WVGP); and co-founder of an equine hospital.